Novanta Inc. $NOVT Shares Acquired by Krane Funds Advisors LLC

Krane Funds Advisors LLC boosted its position in Novanta Inc. (NASDAQ:NOVT) by 903.3% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 15,782 shares of the technology company’s stock after purchasing an additional 14,209 shares during the period. Krane Funds Advisors LLC’s holdings in Novanta were worth $1,676,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. AXQ Capital LP bought a new stake in shares of Novanta in the 3rd quarter worth $257,000. Telemark Asset Management LLC boosted its stake in Novanta by 66.7% during the third quarter. Telemark Asset Management LLC now owns 250,000 shares of the technology company’s stock valued at $25,038,000 after buying an additional 100,000 shares in the last quarter. GSA Capital Partners LLP grew its holdings in Novanta by 59.9% during the third quarter. GSA Capital Partners LLP now owns 3,973 shares of the technology company’s stock worth $398,000 after acquiring an additional 1,488 shares during the period. Summitry LLC raised its position in Novanta by 16.0% in the third quarter. Summitry LLC now owns 3,205 shares of the technology company’s stock worth $321,000 after acquiring an additional 443 shares in the last quarter. Finally, Vanguard Group Inc. raised its position in Novanta by 4.6% in the third quarter. Vanguard Group Inc. now owns 4,378,888 shares of the technology company’s stock worth $438,546,000 after acquiring an additional 193,366 shares in the last quarter. 98.35% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on NOVT shares. Zacks Research raised shares of Novanta from a “strong sell” rating to a “hold” rating in a research note on Friday, January 16th. Weiss Ratings upgraded shares of Novanta from a “sell (d+)” rating to a “hold (c-)” rating in a report on Tuesday, January 20th. Three investment analysts have rated the stock with a Hold rating, According to MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $133.00.

Insider Transactions at Novanta

In other news, CEO Matthijs Glastra sold 7,500 shares of the stock in a transaction that occurred on Tuesday, February 10th. The shares were sold at an average price of $145.04, for a total value of $1,087,800.00. Following the completion of the sale, the chief executive officer directly owned 57,367 shares of the company’s stock, valued at $8,320,509.68. This represents a 11.56% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Robert Buckley sold 1,423 shares of the firm’s stock in a transaction that occurred on Wednesday, January 21st. The stock was sold at an average price of $140.14, for a total transaction of $199,419.22. Following the sale, the chief financial officer owned 91,034 shares of the company’s stock, valued at approximately $12,757,504.76. This represents a 1.54% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 22,923 shares of company stock worth $3,182,264 in the last quarter. 1.20% of the stock is owned by corporate insiders.

Novanta Price Performance

NOVT opened at $142.38 on Tuesday. The firm has a market capitalization of $5.09 billion, a P/E ratio of 96.86 and a beta of 1.62. The stock has a fifty day moving average of $132.15 and a 200-day moving average of $119.89. The company has a quick ratio of 1.54, a current ratio of 2.51 and a debt-to-equity ratio of 0.56. Novanta Inc. has a 12-month low of $98.27 and a 12-month high of $153.20.

Novanta (NASDAQ:NOVT) last issued its quarterly earnings results on Monday, February 23rd. The technology company reported $0.91 earnings per share for the quarter, beating analysts’ consensus estimates of $0.88 by $0.03. The business had revenue of $258.35 million for the quarter, compared to the consensus estimate of $260.72 million. Novanta had a return on equity of 14.53% and a net margin of 5.50%.Novanta has set its FY 2026 guidance at 3.500-3.650 EPS and its Q1 2026 guidance at 0.750-0.800 EPS. Equities analysts forecast that Novanta Inc. will post 3.03 EPS for the current fiscal year.

Trending Headlines about Novanta

Here are the key news stories impacting Novanta this week:

• Positive Sentiment: Headline Q4 results showed growth and an EPS beat: revenue was ~$258.3M (up ~8.5% YoY) and the company reported $0.91 EPS versus a ~ $0.88 consensus, supporting the view of sustained top‑line momentum. Novanta Announces Financial Results for the Fourth Quarter and Full Year 2025
• Positive Sentiment: Balance sheet strength: third‑party data flagged a large increase in cash and cash equivalents (~$381M, +234% YoY), which supports liquidity and buyback/dividend flexibility. Novanta Inc. (NOVT) Stock Falls on Q4 2025 Earnings
• Neutral Sentiment: FY 2026 guidance roughly in line with consensus: Novanta set FY EPS at $3.50–3.65 (consensus ~3.61) and revenue $1.0B–$1.1B — provides a roadmap but leaves upside dependent on execution. Novanta Announces Financial Results for the Fourth Quarter and Full Year 2025
• Neutral Sentiment: Market/valuation discussion and analyst prep pieces are assessing whether recent share momentum is justified given mixed signals from results and guidance. These pieces frame investor debate but don’t introduce new fundamentals. Assessing Novanta (NOVT) Valuation After Recent Share Price Momentum
• Negative Sentiment: Q1 2026 guidance disappointed: Novanta gave Q1 EPS of $0.75–0.80 vs. a ~$0.85 consensus and revenue guidance of $250–255M (vs. $253.3M consensus), prompting near‑term earnings growth concerns. Novanta Announces Financial Results for the Fourth Quarter and Full Year 2025
• Negative Sentiment: Operational/cash concerns flagged by third‑party reporting: operating profit and cash from operations showed strain (reports cite an ~85% drop in cash from ops YoY), and cost of sales rose — potential margin pressure to monitor. Novanta Inc. (NOVT) Stock Falls on Q4 2025 Earnings
• Negative Sentiment: Recent insider selling: the CEO sold shares earlier in Feb., which some investors view as a negative signal about near‑term insider conviction. Is Novanta Stock a Buy or Sell After Its CEO Dumped 6,500 Shares?

About Novanta

Novanta, Inc (NASDAQ: NOVT) is a global technology company that designs and manufactures precision components, subsystems and software used in advanced photonics and motion control applications. The company serves customers in the medical device and advanced industrial markets, supplying critical technologies for diagnostics and therapeutic systems, semiconductor and electronics manufacturing, and scientific instrumentation. Novanta’s product portfolio includes laser control modules, optics, beam delivery systems, high-precision motors, actuators, stages, and fluidics solutions designed to meet stringent accuracy and reliability requirements.

Novanta’s Photonics segment delivers laser and energy delivery components that enable minimally invasive surgical procedures and diagnostic imaging.